chronic pulmonary coccidioidomycosis	is a	fungal infection
coccidioides	is the	fungus causing the infection
chronic pulmonary coccidioidomycosis	can lead to	pulmonary fibrosis
chest X-ray	can detect	pulmonary fibrosis
chronic pulmonary coccidioidomycosis	is treated with	antifungal medications
fluconazole	is an	antifungal medication
chronic pulmonary coccidioidomycosis	may require	surgical intervention
lung transplantation	is a	surgical intervention
chronic pulmonary coccidioidomycosis	increases the risk of	respiratory failure
oxygen therapy	is used for	respiratory failure
chronic pulmonary coccidioidomycosis	can cause	bronchiectasis
pulmonary function test	can diagnose	bronchiectasis
chronic pulmonary coccidioidomycosis	is associated with	chronic cough
codeine	can be used for	chronic cough
chronic pulmonary coccidioidomycosis	may lead to	pleural effusion
thoracentesis	is a procedure for	pleural effusion
chronic pulmonary coccidioidomycosis	can result in	pneumothorax
chest tube insertion	is performed for	pneumothorax
chronic pulmonary coccidioidomycosis	can cause	lung nodules
biopsy	can confirm	lung nodules
chronic pulmonary coccidioidomycosis	is more common in	immunocompromised individuals
HIV infection	is a condition that	can cause immunocompromise
chronic pulmonary coccidioidomycosis	can be asymptomatic in	some cases
serology testing	can detect	asymptomatic cases
chronic pulmonary coccidioidomycosis	can lead to	weight loss
nutritional support	can help manage	weight loss
chronic pulmonary coccidioidomycosis	can result in	fatigue
exercise therapy	can alleviate	fatigue
chronic pulmonary coccidioidomycosis	can cause	night sweats
hyperhidrosis	is a condition characterized by	night sweats
chronic pulmonary coccidioidomycosis	can lead to	chronic pain
pain medication	can be prescribed for	chronic pain
chronic pulmonary coccidioidomycosis	is more prevalent in	certain geographic regions
Valley Fever	is a common name for	chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	is associated with	positive coccidioidin skin test
coccidioidin	is used for	the skin test
chronic pulmonary coccidioidomycosis	is a	fungal infection
coccidioides immitis	is the cause of	chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	is endemic to	southwestern United States
chronic pulmonary coccidioidomycosis	can lead to	lung nodules
amphotericin B	is an	antifungal medication
chronic pulmonary coccidioidomycosis	is diagnosed with	serological tests
chronic pulmonary coccidioidomycosis	may require	lifelong treatment
chronic pulmonary coccidioidomycosis	can cause	lung cavities
chronic pulmonary coccidioidomycosis	is associated with	immunocompromised individuals
chronic pulmonary coccidioidomycosis	can progress to	disseminated disease
chronic pulmonary coccidioidomycosis	may result in	chronic lung symptoms
chronic pulmonary coccidioidomycosis	is treated with	antifungal medications
chronic pulmonary coccidioidomycosis	can lead to	respiratory failure
chronic pulmonary coccidioidomycosis	is characterized by	granulomatous inflammation
chronic pulmonary coccidioidomycosis	can cause	pleural effusion
chronic pulmonary coccidioidomycosis	is a risk factor for	coccidioidal meningitis
chronic pulmonary coccidioidomycosis	can result in	lung fibrosis
chronic pulmonary coccidioidomycosis	is associated with	a history of exposure in endemic areas
fluconazole	is an	antifungal medication
chronic pulmonary coccidioidomycosis	is more common in	men
chronic pulmonary coccidioidomycosis	can cause	weight loss
chronic pulmonary coccidioidomycosis	is more severe in	immunocompromised individuals
chronic pulmonary coccidioidomycosis	is characterized by	granulomatous necrotizing inflammation
chronic pulmonary coccidioidomycosis	can present with	cough and fever
chronic pulmonary coccidioidomycosis	can lead to	lung scarring
chronic pulmonary coccidioidomycosis	is diagnosed with	sputum culture
chronic pulmonary coccidioidomycosis	is more common in	African-Americans and Filipino-Americans
voriconazole	is an	antifungal medication
chronic pulmonary coccidioidomycosis	can cause	pleuritic chest pain
chronic pulmonary coccidioidomycosis	is associated with	outdoor occupations in endemic areas
chronic pulmonary coccidioidomycosis	can cause	night sweats
chronic pulmonary coccidioidomycosis	is challenging to	treat
chronic pulmonary coccidioidomycosis	can lead to	pulmonary hypertension
chronic pulmonary coccidioidomycosis	is more common in	people with diabetes
fluconazole	is used for	long-term treatment of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	is more severe in	pregnant women
chronic pulmonary coccidioidomycosis	can cause	fatigue
chronic pulmonary coccidioidomycosis	is associated with	desert environments
posaconazole	is an	antifungal medication
chronic pulmonary coccidioidomycosis	can lead to	respiratory distress
chronic pulmonary coccidioidomycosis	is more common in	HIV-infected individuals
chronic pulmonary coccidioidomycosis	can cause	arthritis
chronic pulmonary coccidioidomycosis	is diagnosed with	chest radiography
echinocandins	are	antifungal medications
chronic pulmonary coccidioidomycosis	can result in	lung abscess
chronic pulmonary coccidioidomycosis	is more common in	elderly individuals
chronic pulmonary coccidioidomycosis	can cause	skin lesions
chronic pulmonary coccidioidomycosis	is associated with	construction work in endemic areas
itraconazole	is an	antifungal medication
chronic pulmonary coccidioidomycosis	can lead to	bronchiectasis
chronic pulmonary coccidioidomycosis	is more common in	Native Americans
chronic pulmonary coccidioidomycosis	can cause	joint pain
amphotericin B	is used for	severe cases of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can result in	lung collapse
chronic pulmonary coccidioidomycosis	is more severe in	older adults
chronic pulmonary coccidioidomycosis	is characterized by	non-caseating granulomas
chronic pulmonary coccidioidomycosis	can cause	meningitis
chronic pulmonary coccidioidomycosis	is diagnosed with	bronchoscopy
echinocandins	are used for	severe cases of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can lead to	pneumothorax
chronic pulmonary coccidioidomycosis	is more common in	pregnant women
chronic pulmonary coccidioidomycosis	can cause	erythema nodosum
chronic pulmonary coccidioidomycosis	is associated with	Native American ancestry
fluconazole	is used for	maintenance treatment of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can result in	lung nodules with cavitation
chronic pulmonary coccidioidomycosis	is more common in	organ transplant recipients
voriconazole	is used for	severe cases of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can lead to	empyema
chronic pulmonary coccidioidomycosis	is more severe in	people with underlying lung disease
chronic pulmonary coccidioidomycosis	can cause	uveitis
chronic pulmonary coccidioidomycosis	is diagnosed with	lung biopsy
azoles	are	antifungal medications
chronic pulmonary coccidioidomycosis	can result in	lung consolidation
chronic pulmonary coccidioidomycosis	is more common in	African-Americans
posaconazole	is used for	maintenance treatment of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can lead to	lung abscess formation
chronic pulmonary coccidioidomycosis	is more severe in	Hispanic individuals
fluconazole	is used for	mild-moderate cases of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can cause	meningitis
chronic pulmonary coccidioidomycosis	is more common in	immunosuppressed individuals
echinocandins	are used for	treatment of septic arthritis in chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can lead to	lung scarring
chronic pulmonary coccidioidomycosis	is more severe in	people with HIV
chronic pulmonary coccidioidomycosis	can cause	pericarditis
chronic pulmonary coccidioidomycosis	is diagnosed with	PCR testing
amphotericin B	is used for	initial treatment of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can result in	pulmonary fibrosis
chronic pulmonary coccidioidomycosis	is more common in	individuals with a weakened immune system
chronic pulmonary coccidioidomycosis	can cause	erythema multiforme
chronic pulmonary coccidioidomycosis	is associated with	outdoor activities in endemic areas
fluconazole	is used for	chronic suppressive therapy in chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can lead to	lung carcinoma development
chronic pulmonary coccidioidomycosis	is more severe in	smokers
chronic pulmonary coccidioidomycosis	can cause	peritonitis
chronic pulmonary coccidioidomycosis	is diagnosed with	histopathological examination
fluconazole	is used for	long-term maintenance therapy in chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can result in	cavitary lung disease
chronic pulmonary coccidioidomycosis	is more common in	individuals with HIV/AIDS
voriconazole	is used for	treatment of CNS coccidioidomycosis in chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can lead to	respiratory failure
chronic pulmonary coccidioidomycosis	is more severe in	people with underlying immunosuppression
chronic pulmonary coccidioidomycosis	can cause	osteomyelitis
chronic pulmonary coccidioidomycosis	is diagnosed with	immunodiffusion assay
posaconazole	is used for	treatment of CNS coccidioidomycosis in chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can result in	bronchiolitis obliterans
chronic pulmonary coccidioidomycosis	is more common in	people with a history of Valley fever
azoles	are used for	treatment of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can lead to	pulmonary calcifications
chronic pulmonary coccidioidomycosis	is more severe in	elderly individuals
posaconazole	is used for	treatment of severe coccidioidomycosis in chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can cause	myocarditis
chronic pulmonary coccidioidomycosis	is diagnosed with	antigen testing
itraconazole	is used for	treatment of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can result in	pleural thickening
chronic pulmonary coccidioidomycosis	is more common in	people with a history of Valley fever pneumonia
echinocandins	are used for	treatment of invasive coccidioidomycosis in chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can lead to	respiratory distress syndrome
chronic pulmonary coccidioidomycosis	is more severe in	people with a weakened immune system
chronic pulmonary coccidioidomycosis	can cause	endocarditis
chronic pulmonary coccidioidomycosis	is associated with	archaeology work in endemic areas
azoles	are used for	primary treatment of chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can result in	lung nodules with pleural effusion
chronic pulmonary coccidioidomycosis	is more common in	individuals with a history of Valley fever meningitis
voriconazole	is used for	treatment of severe coccidioidomycosis in chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can lead to	lung carcinoma
chronic pulmonary coccidioidomycosis	is more severe in	African-Americans
chronic pulmonary coccidioidomycosis	can cause	endophthalmitis
chronic pulmonary coccidioidomycosis	is diagnosed with	CT scan
itraconazole	is used for	long-term maintenance therapy in chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can result in	lung collapse
chronic pulmonary coccidioidomycosis	is more common in	Pacific Islanders
posaconazole	is used for	treatment of severe coccidioidomycosis in chronic pulmonary coccidioidomycosis
chronic pulmonary coccidioidomycosis	can lead to	pulmonary embolism
chronic pulmonary coccidioidomycosis	is more severe in	Hispanic individuals
chronic pulmonary coccidioidomycosis	can cause	pericardial effusion
chronic pulmonary coccidioidomycosis	is diagnosed with	bronchoalveolar lavage
amphotericin B	is used for	treatment of coccidioidomycosis in chronic pulmonary coccidioidomycosis
